KIR B or not to be?...that is the question for ALL

Michael R. Verneris, Jeffrey S. Miller

Research output: Contribution to journalComment/debatepeer-review

5 Scopus citations


In this issue of Blood, Oevermann et al report on a cohort of 85 children (median age, 10 years) undergoing T-cell-depleted haploidentical hematopoietic cell transplantation (HCT) for acute lymphoblastic leukemia (ALL), where variations in the killer-cell immunoglobulin-like receptor (KIR) gene "content" of the donor were associated with significantly less relapse and improved disease-free survival.

Original languageEnglish (US)
Pages (from-to)2623-2624
Number of pages2
Issue number17
StatePublished - Oct 23 2014

Bibliographical note

Publisher Copyright:
© 2014 by The American Society of Hematology.


Dive into the research topics of 'KIR B or not to be?...that is the question for ALL'. Together they form a unique fingerprint.

Cite this